News

Adherence to Treatment of Multiple Sclerosis: How to Enhance It and What Interesting Insights Emerged from Current Research?
Therapeutic options for patients with multiple sclerosis (MS) utilizing disease-modifying drugs (DMDs) have continued to expand in recent years. However, achieving their full benefit is critically dependent on adherence to treatment. Nonadherence is demonstrably linked to an increased risk of relapses, faster progression of disability, higher treatment costs, and higher mortality. We present a summary of factors affecting adherence to treatment in MS patients, including the influence of the chosen therapy from a 2022 review and subsequent studies.

Teriflunomide in the Treatment of RRMS: The Best Working Drug Is the One That the Patient Actually Takes

Early Tumor Regression as a Marker of Overall Survival in First-Line Treatment of mCRC

Meta-Analysis of the Results of Studies Comparing the Effectiveness of Manual and Sonic Toothbrushes

Is Obesity a Universal Phenotype in Children with Type 2 Diabetes?

Echocardiography in the Diagnosis of Cardiac Amyloidosis

Diagnosis and Management of Therapy for a Breastfeeding Patient with Significant Elevation of Liver Enzymes Postpartum – Interactive Case Study

Empagliflozin will be funded from May for symptomatic heart failure regardless of EF LK value

Current View on Obstacles in Proper Use of Antibiotics and the Role of Biomarkers in Infection Diagnosis

Screenings of Lung Cancer and COPD are Significant. What Do the Latest Data from Czechia Say?
Conferences
News from the world of medicine
All conferences
Popular this week
- Multiple system atrophy
- Intermittent Fasting May Carry Significant Health Risks
- How Compassion Fatigue Threatens Doctors and Other Healthcare Workers
- Tuberous Sclerosis
- Modern approaches enhancing the efficiency of antibiotic therapy in hospital practice